You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dextrose 2.5% And Sodium Chloride 0.33% In Plastic Container, and what generic alternatives are available?

Dextrose 2.5% And Sodium Chloride 0.33% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER?
  • What are the global sales for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER?
Summary for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER
Pharmacology for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631-003 Feb 24, 1988 RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Dextrose 2.5% and Sodium Chloride 0.33% in Plastic Containers

Last updated: March 9, 2026

What is the current scope of the market for Dextrose 2.5% and Sodium Chloride 0.33% in plastic containers?

The intravenous (IV) electrolyte and carbohydrate solutions market continues growth, driven by increased hospital admissions, expanding outpatient care, and demand for parenteral nutrition. The specific segment of Dextrose 2.5% with Sodium Chloride 0.33% in plastic containers is used primarily for hydration, metabolic support, and electrolyte balance.

How large is the global market for these solutions?

The global IV solutions market was valued at USD 8.2 billion in 2022. The electrolyte and glucose solutions account for roughly 45% of this market. The segment proportionally valued at approximately USD 3.69 billion in 2022.

Projected Compound Annual Growth Rate (CAGR) from 2023 to 2028: 5.3%.

This translates into a forecasted market size of USD 4.89 billion by 2028.

Breakdown:

Year Estimated Market Size (USD Billion)
2023 3.89
2024 4.11
2025 4.35
2026 4.62
2027 4.89
2028 5.18

What are the primary drivers influencing this market?

  1. Hospitalization Rates: Rising cases of surgery, trauma, sepsis, and chronic diseases increase demand for parenteral fluids.
  2. Aging Population: Older adults require more IV hydration and electrolyte management, particularly in developed markets.
  3. COVID-19 Pandemic Effects: Increased hospitalizations and ICU stays elevated use of IV solutions.
  4. Regulatory and Safety Standards: Enhanced focus on sterilization, container safety, and manufacturing quality increases the adoption of sealed plastic containers.

How do manufacturing and regulatory factors impact market growth?

Manufacturers must comply with stringent regulations, including FDA standards for aseptic manufacturing, container safety, and labeling. This results in higher production costs and market entry barriers.

The shift toward plastic containers over glass reduces breakage risks, enhances portability, and aligns with safety standards, promoting adoption.

Global regulatory guidance on container material safety influences market shifts. Plastic container standards are set by agencies like the FDA, EMA, and WHO.

What are the key competitive trends?

  • Product Standardization: Market players offer ISO-compliant, pre-packaged solutions with consistent concentration.
  • Innovations: Development of flexible, lightweight, and tamper-evident plastic containers.
  • Brand Consolidation: Large pharmaceutical companies dominate, with some regional players increasing market share.
  • Cost Premiums: High-quality manufacturing and strict compliance increase product prices compared to off-label solutions.

How does geographical distribution influence market dynamics?

Region Market Share (%) Key Factors
North America 40 High healthcare expenditure, advanced healthcare infrastructure, stringent regulations
Europe 25 Aging population, strong hospital networks, regulatory alignment
Asia-Pacific 25 Rapid healthcare infrastructure development, expanding middle class
Latin America 7 Increasing hospital care access, rising awareness of IV therapy
Middle East & Africa 3 Growing outpatient procedures, limited manufacturing bases

North America leads, driven by high hospital capacity, research investments, and regulatory environment favoring sterile plastic containers.

What are the emerging opportunities and challenges?

Opportunities:

  • Expansion into emerging markets.
  • Development of ready-to-use formulations.
  • Incorporation of digital tracking for supply chain integrity.

Challenges:

  • Regulatory delays in approval.
  • Supply chain disruptions affecting raw material availability.
  • Price pressures from generic competitors.
  • Environmental regulations limiting plastic container use, pushing for biodegradable alternatives.

What is the forecasted financial trajectory?

Revenue growth is expected to sustain at a CAGR of approximately 5.3% over five years, driven primarily by increased demand and innovation in container technology.

Price points:

  • Standard Dextrose 2.5% + Sodium Chloride 0.33% solutions in plastic containers currently retail for USD 0.50 – 1.50 per sterile unit.
  • Premium branded products in hospital settings command higher margins.

Profitability depends on scale economies, regulatory compliance costs, and market share gains. Larger players are investing in advanced manufacturing capacity, which suggests potentially increasing margins through operational efficiencies.

What are the implications for stakeholders?

  • Manufacturers: Focus on innovation, regulatory compliance, and cost management.
  • Investors: Monitor regulatory policies, manufacturing capacity expansion, and regional market penetration.
  • Healthcare providers: Seek reliable, safe, and cost-effective IV solutions.
  • Regulators: Emphasize container safety, sterility, and environmental impact.

Key Takeaways

  • The global IV electrolyte and glucose solution market is projected to grow to USD 5.18 billion by 2028, CAGR of 5.3%.
  • North America and Europe dominate due to healthcare infrastructure and regulatory standards.
  • Market growth relies on hospital admission rates, aging populations, and technological advancements in plastic container manufacturing.
  • Cost, regulatory compliance, and container safety are critical factors influencing market dynamics.
  • Emerging markets present significant expansion opportunity, especially with product innovation and infrastructure development.

FAQs

1. How does the shift from glass to plastic containers impact market growth?

Plastic containers reduce breakage, improve safety, and meet regulatory standards more easily, expediting market expansion. They also allow for innovative packaging formats, influencing product development and adoption.

2. What are the regulatory challenges associated with these solutions?

Regulatory agencies enforce standards for sterility, container safety (biocompatibility, migration limits), and manufacturing practices. Delays in approval processes can hinder product launch timelines.

3. What innovations are influencing the market?

Use of tamper-evident seals, lightweight adhesives, biodegradable plastics, and integrated digital tracking systems are shaping product differentiation and safety.

4. How do regional differences affect market strategies?

Manufacturers tailor their strategies according to local regulatory environments, healthcare infrastructure, and market maturity, focusing on establishing manufacturing bases or forming partnerships.

5. What environmental considerations impact future market developments?

Regulations aim to reduce plastic waste and promote biodegradable or recyclable containers. Manufacturers investing in eco-friendly materials may face higher upfront costs but gain regulatory favor and market share.


References:

[1] MarketsandMarkets. (2023). IV Solutions Market by Type, Region, and Application Forecast.

[2] Mordor Intelligence. (2022). Parenteral Nutrition and IV Solutions Market Analysis.

[3] U.S. Food and Drug Administration (FDA). (2022). Guidance for Industry: Container Closure Systems.

[4] World Health Organization (WHO). (2021). Medical Waste Management Policies.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.